Hou Tingjun, Zhang Wei, Xu Xiaojie
College of Chemistry and Molecular Engineering, Peking University, Beijing, PR China.
J Comput Aided Mol Des. 2002 Jan;16(1):27-41. doi: 10.1023/a:1016345810973.
We have performed docking and molecular dynamics simulations of hydroxamates complexed with human gelatinase-A (MMP-2) to gain insight into the structural and energetic preferences of these inhibitors. The study was conducted on a selected set of eleven compounds with variation in structure and activity. Molecular dynamics simulations were performed at 300 K for 100 ps with equilibration for 50 ps. The structural analyses of the trajectories indicate that the coordinate bond interactions, the hydrogen bond interactions, the van der Waals interactions as well as the hydrophobic interactions between ligand and receptor are responsible simultaneously for the preference of inhibition and potency. The ligand hydroxamate group is coordinated to the catalytic zinc ion and form stable hydrogen bonds with the carbonyl oxygen of Gly 162. The P1' group makes extensive van der Waals and hydrophobic contacts with the nonpolar side chains of several residues in the S1' subsite, including Leu 197, Val 198, Leu 218 and Tyr 223. Moreover, four to eight hydrogen bonds between hydroxamates and MMP-2 are formed to stabilize the inhibitors in the active site. Compared with the P2' and P3' groups, the P1' groups of inhibitors are oriented regularly, which is produced by the restrain of the S1' subsite. From the relationship between the length of the nonpolar P1' group and the biological activity, we confirm that MMP-2 has a pocket-like S1' subsite, not a channel-like S1' subsite proposed by Kiyama (Kiyama, R. et al., J. Med. Chem. 42 (1999), 1723). The energetic analyses show that the experimental binding free energies can be well correlated with the interactions between the inhibitors and their environments, which could be used as a simple score function to evaluate the binding affinities for other similar hydroxamates. The validity of the force field parameters and the MD simulations can be fully testified by the satisfactory agreements between the experimental structure-activity relationship and the information from the structural and energetic analyses. The information generated from the predicted complexes should be useful for further work in the area of structure-based design of new compounds.
我们对与人明胶酶 -A(基质金属蛋白酶 -2,MMP -2)复合的异羟肟酸进行了对接和分子动力学模拟,以深入了解这些抑制剂的结构和能量偏好。该研究针对一组选定的十一种结构和活性各异的化合物展开。分子动力学模拟在300 K下进行100 ps,并进行50 ps的平衡。轨迹的结构分析表明,配体与受体之间的配位键相互作用、氢键相互作用、范德华相互作用以及疏水相互作用同时决定了抑制作用的偏好性和效力。配体异羟肟酸基团与催化锌离子配位,并与Gly 162的羰基氧形成稳定的氢键。P1'基团与S1'亚位点中几个残基的非极性侧链(包括Leu 197、Val 198、Leu 218和Tyr 223)形成广泛的范德华和疏水接触。此外,异羟肟酸与MMP -2之间形成四到八个氢键,以将抑制剂稳定在活性位点。与P2'和P3'基团相比,抑制剂的P1'基团排列规则,这是由S1'亚位点的限制作用产生的。从非极性P1'基团的长度与生物活性之间的关系,我们证实MMP -2具有口袋状的S1'亚位点,而非Kiyama提出的通道状S1'亚位点(Kiyama, R.等人,《药物化学杂志》42 (1999), 1723)。能量分析表明,实验结合自由能与抑制剂及其环境之间的相互作用具有良好的相关性,这可作为一个简单的评分函数来评估其他类似异羟肟酸的结合亲和力。实验结构 - 活性关系与结构和能量分析信息之间令人满意的一致性充分证明了力场参数和分子动力学模拟的有效性。预测复合物产生的信息对于基于结构的新化合物设计领域的进一步工作应是有用的。